AI Use in Prostate Cancer: Potential Improvements in Treatments and Patient Care.

IF 1.8 4区医学 Q3 ONCOLOGY

Oncology-New York Pub Date : 2024-05-13 DOI:10.46883/2024.25921021

James B Yu Md Mhs Fastro, Julian C Hong

引用次数: 0

Abstract

Artificial intelligence use in prostate cancer encompasses 4 main areas including diagnostic imaging, prediction of outcomes, histopathology, and treatment planning.

查看原文本刊更多论文

人工智能在前列腺癌中的应用：治疗和患者护理的潜在改进。

人工智能在前列腺癌中的应用主要包括 4 个方面，包括诊断成像、结果预测、组织病理学和治疗规划。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Oncology-New York 肿瘤学-肿瘤学

CiteScore

1.60

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： Although laboratory and clinical cancer research need to be closely linked, observations at the basic level often remain removed from medical applications. This journal works to accelerate the translation of experimental results into the clinic, and back again into the laboratory for further investigation. The fundamental purpose of this effort is to advance clinically-relevant knowledge of cancer, and improve the outcome of prevention, diagnosis and treatment of malignant disease. The journal publishes significant clinical studies from cancer programs around the world, along with important translational laboratory findings, mini-reviews (invited and submitted) and in-depth discussions of evolving and controversial topics in the oncology arena. A unique feature of the journal is a new section which focuses on rapid peer-review and subsequent publication of short reports of phase 1 and phase 2 clinical cancer trials, with a goal of insuring that high-quality clinical cancer research quickly enters the public domain, regardless of the trial’s ultimate conclusions regarding efficacy or toxicity.